Physician profile
Sarah A Stout
NPI 1124377247
$1,573.46
in general payments reported to CMS, 2019-2025
14 companies · $423 in 2025
The $423 reported for 2025 was more than what a typical Physician Assistant provider received nationally (typical 2025 total: $183).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $55.41 · 2022: $346 · 2023: $324 · 2024: $425 · 2025: $423.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,163 · Education: $8.90.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,163.05 |
| Education | $8.90 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Novo Nordisk INC | $696.52 | 2021-2025 | Wegovy, Saxenda |
| Abbvie INC. | $276.98 | 2021-2025 | |
| Lilly USA, LLC | $120.08 | 2023-2025 | Zepbound, Mounjaro, Jardiance |
| Vivus LLC | $113.28 | 2022-2024 | Qsymia |
| Iti, INC. (D/B/A Intra-Cellular Therapies, INC.) | $84.52 | 2022 | |
| Tela Bio, INC. | $59.09 | 2025 | Ovitex Reinforced Bioscaffold With Permanent Polymer (Ovitex) |
| Takeda Pharmaceuticals U.S.A., INC. | $49.78 | 2023-2024 | Gattex |
| Aimmune Therapeutics, INC. | $40.29 | 2024-2025 | Zenpep |
| Ethicon US, LLC | $36.04 | 2022-2024 | Linx Reflux Management System |
| Nestle Healthcare Nutrition INC. | $32.50 | 2023 | |
| Heron Therapeutics, INC. | $20.62 | 2022 | |
| Pacira Pharmaceuticals Incorporated | $15.78 | 2024 | Iovera, Zilretta, Exparel |
| Intra-Sana Laboratories | $15.45 | 2024 | Reltone 400 Mg, Reltone 200 Mg, Glycate |
| Boston Scientific Corporation | $12.53 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Sarah Stout listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.